Anatara Lifesciences Ltd (AU:ANR) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Anatara Lifesciences Limited has announced a change in the director’s interests, with John Michailidis acquiring 359,640 performance rights following shareholder approval at their recent AGM. This update indicates potential strategic moves within the company that may interest investors watching director activities closely.
For further insights into AU:ANR stock, check out TipRanks’ Stock Analysis page.